NVCT

NUVECTIS PHARMA INC

NVCT·67080T108·US·Common Stock·Healthcare - Biotechnology

NVCT (NUVECTIS PHARMA INC) is held by 41 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($5.9M), VANGUARD CAPITAL MANAGEMENT LLC ($5.1M), GEODE CAPITAL MANAGEMENT, LLC ($3M). Net institutional sentiment: Bullish.

41
Holders
Avg rating(9 Elite)
$22.1M
Total Value
76% (41)
Fund Consensus
26 buying - 8 selling
NVCTSmart Money Verdict
View all
Held by 41 funds
9 elite
Who's Trading
InsiderBRBENTSUR RONBuy $29KNov 5, 2025
InsiderKLKaplan Matthew L.Buy $64KNov 5, 2025
InsiderSJSanchez JuanBuy $75KNov 5, 2025
InsiderMCMosseri Marlio CharlesBuy $457KOct 27, 2025
InsiderMCMosseri Marlio CharlesBuy $215KOct 24, 2025
InsiderMCMosseri Marlio CharlesBuy $284KOct 23, 2025
InsiderMCMosseri Marlio CharlesBuy $45KJun 20, 2025
InsiderMCMosseri Marlio CharlesBuy $226KJun 18, 2025
InsiderMCMosseri Marlio CharlesBuy $44KJun 17, 2025
InsiderMCMosseri Marlio CharlesBuy $21KMay 8, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
764,441(-2.4%)$5.9M0.0%+152.36%
0
New
659,879$5.1M0.0%+110.68%
37
Increased
384,105(+5.5%)$3M0.0%+113.47%
28
Increased
166,516(+7.7%)$1.3M0.0%+145.89%
19
Increased
124,212(+6.7%)$960,1590.0%+112.88%
27
New
114,842$887,7290.0%+110.68%
34
Decreased
105,286(-21.5%)$813,8610.0%+164.37%
0
New
92,154$712,3500.0%+110.68%
38
New
78,425$606,2250.0%+110.68%
34
Increased
49,645(+12.8%)$383,7560.0%+139.53%
27
Increased
41,124(+55.2%)$317,8890.0%+165.48%
23
Increased
38,563(+360.4%)$298,0920.0%+116.13%
26
Decreased
30,315(-4.2%)$234,3320.0%+145.06%
0
New
29,223$225,8940.0%+110.68%
32
New
25,662$198,3680.0%+110.68%
32
Decreased
22,568(-19.4%)$174,4510.0%+135.88%
0
Unchanged
16,749$129,4700.0%+143.05%
0
Increased
14,847(+10.2%)$114,7680.0%+149.43%
16
Unchanged
12,672$97,9540.0%+148.49%
0
New
12,048$94,0000.0%+110.68%
33

Showing 1-20 of 41

1 / 3

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used